Exploring the effect of PARP-1 flexibility in docking studies.

Area of Science:

• Biochemistry
• Computational Biology
• Pharmacology

Background:

• Poly(ADP-ribose)polymerase-1 (PARP-1) is a crucial enzyme in DNA repair and a validated drug target for cancer and ischemia.
• Understanding PARP-1's conformational dynamics is essential for advancing structure-based drug discovery.

Purpose of the Study:

• To explore the conformational landscape of the PARP-1 catalytic domain using molecular dynamics.
• To evaluate the impact of enzyme flexibility on the efficacy of drug docking simulations for PARP-1 inhibitors.

Main Methods:

• Replica Exchange Molecular Dynamics (REMD) simulations were employed to sample conformational states of PARP-1.
• Docking experiments were performed using generated conformations to assess inhibitor binding affinity and enrichment.

Main Results:

• Conformational shifts involving residues Leu324, Tyr325, and Lys242 were identified as critical.
• These shifts were shown to modulate an additional binding pocket, influencing ligand interactions within the catalytic cleft.
• Using REMD-generated conformations significantly improved the enrichment factor of active PARP-1 inhibitors in docking studies.

Conclusions:

• Enzyme flexibility, particularly involving specific residues, plays a significant role in PARP-1 inhibitor binding.
• Incorporating REMD-derived conformations enhances the accuracy and predictive power of docking simulations for drug discovery targeting PARP-1.